{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:27:21Z","timestamp":1777994841636,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI","award":["U01CA140204"],"award-info":[{"award-number":["U01CA140204"]}]},{"name":"R01","award":["CA134675"],"award-info":[{"award-number":["CA134675"]}]},{"name":"T32","award":["T32EB006351"],"award-info":[{"award-number":["T32EB006351"]}]},{"name":"P41","award":["EB024405"],"award-info":[{"award-number":["EB024405"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-024-01104-y","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T15:02:12Z","timestamp":1712588532000},"page":"2206-2215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["An Automated\u00a0Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET\/CT Imaging of Patients with Prostate Cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[]},{"given":"Maliha R.","family":"Imami","sequence":"additional","affiliation":[]},{"given":"Linmei","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Alireza","family":"Amindarolzarbi","sequence":"additional","affiliation":[]},{"given":"Esther","family":"Mena","sequence":"additional","affiliation":[]},{"given":"Jeffrey","family":"Leal","sequence":"additional","affiliation":[]},{"given":"Junyu","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Andrei","family":"Gafita","sequence":"additional","affiliation":[]},{"given":"Andrew F.","family":"Voter","sequence":"additional","affiliation":[]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Du","sequence":"additional","affiliation":[]},{"given":"Chengzhang","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[]},{"given":"Beiji","family":"Zou","sequence":"additional","affiliation":[]},{"given":"Zhicheng","family":"Jiao","sequence":"additional","affiliation":[]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[]},{"given":"Harrison X.","family":"Bai","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends\u2014An Update Global Cancer Rates and Trends\u2014An Update. Cancer Epidemiol Biomarkers Prev. 2016; 25:16-27. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0578.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"1104_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71:209-249. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"issue":"10","key":"1104_CR3","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.3390\/biomedicines10102533","volume":"10","author":"M Li","year":"2022","unstructured":"Li M, Zelchan R, Orlova A. The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer. Biomedicines. 2022;10(10), 2533. https:\/\/doi.org\/10.3390\/biomedicines10102533.","journal-title":"Biomedicines."},{"key":"1104_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14737140.2022.2081155","volume":"22","author":"AF Voter","year":"2022","unstructured":"Voter AF, Werner RA, Pienta KJ, et al. Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer. Expert Rev Anticancer Ther. 2022; 22:681-694. https:\/\/doi.org\/10.1080\/14737140.2022.2081155.","journal-title":"Expert Rev Anticancer Ther."},{"key":"1104_CR5","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020; 395:1208-1216. https:\/\/doi.org\/10.1016\/S0140-6736(20)30314-7.","journal-title":"Lancet."},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1007\/s00259-022-05905-7","volume":"49","author":"S An","year":"2022","unstructured":"An S, Huang G, Liu J, Wei W. PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers. Eur J Nucl Med Mol Imaging. 2022; 49:3973-3976. https:\/\/doi.org\/10.1007\/s00259-022-05905-7.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"7056983","DOI":"10.1155\/2022\/7056983","volume":"2022","author":"RA Werner","year":"2022","unstructured":"Werner RA, Habacha B, L\u00fctje S, et al. High SUVs have more robust repeatability in patients with metastatic prostate cancer: Results from a prospective test-retest cohort imaged with 18F-DCFPyL. Mol Imaging. 2022; 2022:7056983. https:\/\/doi.org\/10.1155\/2022\/7056983.","journal-title":"Mol Imaging."},{"key":"1104_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2967\/jnumed.118.224055","volume":"60","author":"A Gafita","year":"2019","unstructured":"Gafita A, Bieth M, Kr\u00f6nke M, et al. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET\/CT. J Nucl Med. 2019;60:1277-1283. https:\/\/doi.org\/10.2967\/jnumed.118.224055.","journal-title":"J Nucl Med."},{"issue":"7","key":"1104_CR9","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1007\/s00259-023-06163-x","volume":"50","author":"M Kim","year":"2023","unstructured":"Kim M, Seifert R, Fragemann J, et al. Evaluation of thresholding methods for the quantification of [68Ga] Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy. Eur J Nucl Med Mol Imaging. 2023, 50(7), 2196\u20132209. https:\/\/doi.org\/10.1007\/s00259-023-06163-x","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1104_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2020.101759","volume":"65","author":"D Karimi","year":"2020","unstructured":"Karimi D, Dou H, Warfield SK, Gholipour A. Deep learning with noisy labels: Exploring techniques and remedies in medical image analysis. Med Image Anal. 2020; 65:101759. https:\/\/doi.org\/10.1016\/j.media.2020.101759.","journal-title":"Med Image Anal."},{"key":"1104_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2021.102062","volume":"71","author":"S Budd","year":"2021","unstructured":"Budd S, Robinson EC, Kainz B. A survey on active learning and human-in-the-loop deep learning for medical image analysis. Med Image Anal. 2021; 71:102062. https:\/\/doi.org\/10.1016\/j.media.2021.102062.","journal-title":"Med Image Anal."},{"key":"1104_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2022.102684","volume":"84","author":"W Jin","year":"2023","unstructured":"Jin W, Li X, Fatehi M, Hamarneh G. Guidelines and evaluation of clinical explainable AI in medical image analysis. Med Image Anal. 2023; 84:102684. https:\/\/doi.org\/10.1016\/j.media.2022.102684.","journal-title":"Med Image Anal."},{"key":"1104_CR13","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s11831-023-09898-w","volume":"30","author":"SS Kshatri","year":"2023","unstructured":"Kshatri SS, Singh D. Convolutional Neural Network in Medical Image Analysis: A Review. Arch Comput Methods Eng. 2023; 30:2793-2810. https:\/\/doi.org\/10.1007\/s11831-023-09898-w.","journal-title":"Arch Comput Methods Eng."},{"key":"1104_CR14","doi-asserted-by":"publisher","unstructured":"Salpea N, Tzouveli P, Kollias D. Medical Image Segmentation: A Review of Modern Architectures.  In: Karlinsky, L., Michaeli, T., Nishino, K. (eds) Computer Vision \u2013 ECCV 2022 Workshops. ECCV 2022. Lecture Notes in Computer Science, vol 13807. Springer, Cham.  https:\/\/doi.org\/10.1007\/978-3-031-25082-8_47.","DOI":"10.1007\/978-3-031-25082-8_47"},{"issue":"1","key":"1104_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-022-05927-1","volume":"50","author":"J Kendrick","year":"2020","unstructured":"Kendrick J, Francis R J, Hassan G M, et al. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga] Ga-PSMA-11 PET\/CT images. Eur J Nucl Med Mol Imaging. 2020, 50(1), 67-79. https:\/\/doi.org\/10.1007\/s00259-022-05927-1.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1104_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1148\/radiol.2019191114","volume":"294","author":"L Sibille","year":"2020","unstructured":"Sibille L, Seifert R, Avramovic N, et al. 18F-FDG PET\/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks. Radiology. 2020; 294:445-452. https:\/\/doi.org\/10.1148\/radiol.2019191114.","journal-title":"Radiology."},{"key":"1104_CR17","doi-asserted-by":"publisher","unstructured":"Yixi X, Ivan K, Sara H, et al. Automatic segmentation of prostate cancer metastases in PSMA PET\/CT images using deep neural networks with weighted batch-wise dice loss. Computers in Biology and Medicine. 2023;158:106882. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106882.","DOI":"10.1016\/j.compbiomed.2023.106882"},{"issue":"23","key":"1104_CR18","doi-asserted-by":"publisher","first-page":"00049","DOI":"10.1053\/j.semnuclmed.2023.06.001","volume":"S0001\u20132998","author":"S Lindgren Belal","year":"2023","unstructured":"Lindgren Belal S, Frantz S, Minarik D, et al. Applications of Artificial Intelligence in PSMA PET\/CT for Prostate Cancer Imaging. Semin Nucl Med. 2023;S0001-2998(23)00049-1. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.06.001.","journal-title":"Semin Nucl Med."},{"key":"1104_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.2967\/jnumed.121.262347","volume":"63","author":"E Mena","year":"2022","unstructured":"Mena E, Rowe SP, Shih JH, et al. Predictors of 18F-DCFPyL PET\/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy. J Nucl Med. 2022; 63:1184-1190. https:\/\/doi.org\/10.2967\/jnumed.121.262347.","journal-title":"J Nucl Med."},{"key":"1104_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.37894","volume":"10","author":"RA Werner","year":"2020","unstructured":"Werner RA, Derlin T, Lapa C, et al. 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging. Theranostics. 2020; 10:1-16. https:\/\/doi.org\/10.7150\/thno.37894.","journal-title":"Theranostics."},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/a-1659-0010","volume":"61","author":"SP Rowe","year":"2022","unstructured":"Rowe SP, Buck A, Bundschuh RA, et al. [18F] DCFPyL PET\/CT for imaging of prostate cancer. Nuklearmedizin. 2022; 61:240-246. https:\/\/doi.org\/10.1055\/a-1659-0010.","journal-title":"Nuklearmedizin."},{"key":"1104_CR22","doi-asserted-by":"publisher","unstructured":"Yechiel Y, Orr Y, Gurevich K, Gill R, Keidar Z. Advanced PSMA-PET\/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease. Cancers. 2023;15(4):1020. https:\/\/doi.org\/10.3390\/cancers15041020.","DOI":"10.3390\/cancers15041020"},{"key":"1104_CR23","doi-asserted-by":"publisher","unstructured":"Vaswani A, Shazeer N, Parmar N, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30. https:\/\/doi.org\/10.48550\/arXiv.1706.03762.","DOI":"10.48550\/arXiv.1706.03762"},{"key":"1104_CR24","doi-asserted-by":"publisher","unstructured":"Dosovitskiy A, Beyer L, Kolesnikov A, et al. An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale. arXiv preprint arXiv:11929 2020. https:\/\/doi.org\/10.48550\/arXiv.2010.11929.","DOI":"10.48550\/arXiv.2010.11929"},{"key":"1104_CR25","doi-asserted-by":"publisher","unstructured":"Hatamizadeh A, Tang Y, Nath V, et al. UNETR: Transformers for 3D Medical Image Segmentation. Proceedings of the IEEE\/CVF winter conference on applications of computer vision; 2022. p. 574-84. https:\/\/doi.org\/10.48550\/arXiv.2103.10504.","DOI":"10.48550\/arXiv.2103.10504"},{"key":"1104_CR26","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00259-018-4042-z","volume":"45","author":"C Schmidkonz","year":"2018","unstructured":"Schmidkonz C, Cordes M, Schmidt D, et al. 68Ga-PSMA-11 PET\/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. Eur J Nucl Med Mol Imaging. 2018; 45:1862-1872. https:\/\/doi.org\/10.1007\/s00259-018-4042-z.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.2967\/jnumed.117.193581","volume":"58","author":"S Schmuck","year":"2017","unstructured":"Schmuck S, von Klot CA, Henkenberens C, et al. Initial experience with volumetric 68Ga-PSMA I&T PET\/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with prostate cancer. J Nucl Med. 2017; 58:1962-1968. https:\/\/doi.org\/10.2967\/jnumed.117.193581.","journal-title":"J Nucl Med."},{"key":"1104_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105620","volume":"147","author":"S Gul","year":"2022","unstructured":"Gul S, Khan MS, Bibi A, Khandakar A, Ayari MA, Chowdhury MEH. Deep learning techniques for liver and liver tumor segmentation: A review. Comput Biol Med. 2022; 147:105620. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105620.","journal-title":"Comput Biol Med."},{"key":"1104_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jcde\/qwac141","volume":"10","author":"YMA Mohammed","year":"2023","unstructured":"Mohammed YMA, El Garouani S, Jellouli I. A survey of methods for brain tumor segmentation-based MRI images. Finite Elem Anal Des. 2023; 10:266-293. https:\/\/doi.org\/10.1093\/jcde\/qwac141.","journal-title":"Finite Elem Anal Des."},{"key":"1104_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s13139-022-00745-7","volume":"57","author":"J Park","year":"2023","unstructured":"Park J, Kang SK, Hwang D, et al. Automatic Lung Cancer Segmentation in [18F] FDG PET\/CT Using a Two-Stage Deep Learning Approach. Nucl Med Mol Imaging. 2023; 57:86-93. https:\/\/doi.org\/10.1007\/s13139-022-00745-7.","journal-title":"Nucl Med Mol Imaging."},{"issue":"12","key":"1104_CR31","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.120.242057","volume":"61","author":"R Seifert","year":"2020","unstructured":"Seifert R, Herrmann K, Kleesiek J, et al. Semiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer. J Nucl Med. 2020; 61(12):1786-1792. https:\/\/doi.org\/10.2967\/jnumed.120.242057.","journal-title":"J Nucl Med."},{"key":"1104_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00259-021-05497-8","volume":"49","author":"K Johnsson","year":"2022","unstructured":"Johnsson K, Brynolfsson J, Sahlstedt H, et al. Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F] DCFPyL (PSMA) imaging for standardized reporting. Eur J Nucl Med Mol Imaging. 2022; 49:1041-1051. https:\/\/doi.org\/10.1007\/s00259-021-05497-8.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1104_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2967\/jnumed.120.261863","volume":"63","author":"N Nickols","year":"2022","unstructured":"Nickols N, Anand A, Johnsson K, et al. aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL Images of Veterans with Prostate Cancer. J Nucl Med. 2022; 63:233-239. https:\/\/doi.org\/10.2967\/jnumed.120.261863.","journal-title":"J Nucl Med."},{"key":"1104_CR34","doi-asserted-by":"publisher","unstructured":"Kendrick J, Francis RJ, Hassan GM. et al. Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga] Ga-PSMA-11 PET images. Eur J Nucl Med Mol Imaging. 2023;50:4077-86. https:\/\/doi.org\/10.1007\/s00259-023-06382-2.","DOI":"10.1007\/s00259-023-06382-2"},{"key":"1104_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00259-021-05473-2","volume":"49","author":"N Capobianco","year":"2022","unstructured":"36. Capobianco N, Sibille L, Chantadisai M, et al. Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET\/CT using dual-tracer learning. Eur J Nucl Med Mol Imaging. 2022; 49:517-526. https:\/\/doi.org\/10.1007\/s00259-021-05473-2.","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-024-01104-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:29:54Z","timestamp":1730190594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-024-01104-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s10278-024-01104-y","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.G.P. is co-inventor on a US patent covering <sup>18<\/sup>F-DCFPyL and as such is entitled to a portion of any licensing fees and royalties generated by this technology. The arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. S.P.R. is a consultant to Progenics Pharmaceuticals, the licensee of <sup>18<\/sup>F-DCFPyL. M.G.P and S.P.R receive research funding from Progenics Pharmaceuticals. No other potential conflicts of interest relevant to this article exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}